文献速递免疫规划传染病防控与疫情报告

2018/19年加拿大甲型H3N2流感流行期间 paradoxical 分支和年龄特异性疫苗有效性:疫苗印迹调节效应(I-REV)的潜在作用

Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV).
PubMed 文献 · Euro Surveill · 2019-01-01

加拿大哨点执业医师监测网络报告2018/19年甲型H3N2流感流行期间疫苗有效性(VE)。采用检测阴性设计评估总体及分支3C.2a1b和3C.3a的VE,并比较2018/19年VE随年龄变化与1968年以来血凝素糖蛋白氨基酸变异。总体VE为17%(95%CI:-13至39),3C.3a为-32%(95%CI:-119至21),35-54岁接种者中3C.3a VE呈显著负值,接种者就医风险较未接种者增加4倍以上(p<0.005)。作者假设儿童期免疫印迹和1968年流感大流行后队列效应可解释该矛盾信号。

要点

  • 2018/19年甲型H3N2总体VE为17%(95%CI:-13至39),3C.2a1b为27%(95%CI:-7至50),3C.3a为-32%(95%CI:-119至21)。
  • 20-64岁人群总体VE为-7%(95%CI:-56至26),3C.3a为-96%(95%CI:-277至-2)。
  • 35-54岁接种者中3C.3a VE呈显著负值,就医风险较未接种者增加4倍以上(p<0.005)。

核心结论

  • 2018/19年加拿大甲型H3N2疫苗有效性总体较低,分支3C.3a在35-54岁接种者中呈现 paradoxical 负有效性信号,作者提出儿童期免疫印迹与疫苗株不匹配的交互作用可能解释该现象,其免疫学机制值得研究。

研究设计与样本

  • 加拿大哨点执业医师监测网络采用检测阴性设计评估2018/19年甲型H3N2流感疫苗有效性,并比较VE随年龄变化与1968年以来血凝素糖蛋白氨基酸变异。

主要发现

  • 总体甲型H3N2 VE为17%(95%CI:-13至39),3C.2a1b VE为27%(95%CI:-7至50),3C.3a VE为-32%(95%CI:-119至21)。
  • 20-64岁人群总体VE为-7%(95%CI:-56至26),3C.2a1b为6%(95%CI:-49至41),3C.3a为-96%(95%CI:-277至-2)。
  • 35-54岁人群中3C.3a VE呈显著负值,接种者就医风险较未接种者增加4倍以上(p<0.005)。
  • 该年龄组儿童期所遇甲型H3N2病毒在1968年大流行后二十年间血凝素第159位为丝氨酸,与当代3C.3a病毒相同但与3C.2a疫苗株的酪氨酸不匹配。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IntroductionThe Canadian Sentinel Practitioner Surveillance Network reports vaccine effectiveness (VE) for the 2018/19 influenza A(H3N2) epidemic.AimTo explain a paradoxical signal of increased clade 3C.3a risk among 35-54-year-old vaccinees, we hypothesise childhood immunological imprinting and a cohort effect following the 1968 influenza A(H3N2) pandemic.MethodsWe assessed VE by test-negative design for influenza A(H3N2) overall and for co-circulating clades 3C.2a1b and 3C.3a. VE variation by age in 2018/19 was compared with amino acid variation in the haemagglutinin glycoprotein by year since 1968.ResultsInfluenza A(H3N2) VE was 17% (95% CI: -13 to 39) overall: 27% (95% CI: -7 to 50) for 3C.2a1b and -32% (95% CI: -119 to 21) for 3C.3a. Among 20-64-year-olds, VE was -7% (95% CI: -56 to 26): 6% (95% CI: -49 to 41) for 3C.2a1b and -96% (95% CI: -277 to -2) for 3C.3a. Clade 3C.3a VE showed a pronounced negative dip among 35-54-year-olds in whom the odds of medically attended illness were > 4-fold increased for vaccinated vs unvaccinated participants (p < 0.005). This age group was primed in childhood to influenza A(H3N2) viruses that for two decades following the 1968 pandemic bore a serine at haemagglutinin position 159, in common with contemporary 3C.3a viruses but mismatched to 3C.2a vaccine strains instead bearing tyrosine.DiscussionImprinting by the first childhood influenza infection is known to confer long-lasting immunity focused toward priming epitopes. Our findings suggest vaccine mismatch may negatively interact with imprinted immunity. The immunological mechanisms for imprint-regulated effect of vaccine (I-REV) warrant investigation.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Skowronski DM, Sabaiduc S, Leir S, et al. Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV). Euro Surveill. 2019. PMID: 31771709. doi:10.2807/1560-7917.ES.2019.24.46.1900585

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。